大剂量脉络宁对急性心肌梗塞溶栓治疗再灌注性损伤的防治  被引量:14

Preventive effect of high dosage “mai luo ning” on reperfusion injury after thrombolytic therapy in patients with acute myocardial infarction

在线阅读下载全文

作  者:王维展[1,2] 岳爱菊[1,2] 张颖轩[1,2] 武长东 陈玉生[1,2] 沈立[1,2] 耿建林[1,2] 郭丽娟[1,2] 

机构地区:[1]河北省衡水市哈励逊国际和平医院 [2]枣强县嘉会医院

出  处:《中国危重病急救医学》1997年第8期464-466,共3页Chinese Critical Care Medicine

基  金:河北省科研基金

摘  要:目的:探讨急性心肌梗塞(AMI)再灌注性损伤的防治方法。方法:选择具有溶栓指征的AMI患者138例,随机分为治疗组与对照组(各69例)。2组均进行尿激酶静脉溶栓治疗。治疗组在用尿激酶前10~30分钟或同时应用脉络宁40~50ml,每天1次,连用7天。对照组只用尿激酶及常规治疗。结果:治疗组与对照组再通分别为53例(76.8%)和49例(71.0%);住院期间死亡分别为2例(2.9%)和6例(8.7%);发生严重心力衰竭分别为4例(5.8%)和7例(10.1%);发生再灌注性心律失常分别为22例(31.9%)和38例(55.1%),2组比较差异均显著(P<0.05或<0.01)。同时,治疗组在减少心肌耗氧量、缩小梗塞面积、减少心肌酶的释放和提高左室射血功能等方面都显著优于对照组(P均<0.05)。结论:大剂量脉络宁具有抗AMI再灌注性损伤的作用,并且以连用7天为宜。Objective:To explore the potential measures for prevention and treatment of reperfusion injury in patients with acute myocardial infarction (AMI).Methods:One hundred and thirtyeight patients with AMI receiving thrombolytic therapy were included in this study.Patients were randomly divided into treatment group and control group,and all received urokinase injection.In treatment group,“mai luo ning”(40~50 ml)was injected 10 ̄30 minutes before or at the same time as the urokinase treatment,and it was given once a day and continued for 1 week.But control group received only urokinase and conventional treatment.Results:Reperfusion rate and mortality were 76 8% (53 cases) and 2 9% (2 cases ) in treatment group,and 71 0%(49 cases) and 8 7% (6 cases) in control group respectively.Also,it was shown that incidences of heart failure and reperfusion arrhythmia were 5 8% (4 cases)and 31 9% (22 cases) in treatment group,and 10 1%(7 cases) and 55 1%(38 cases) in control group respectively,and these differences were significant( P <0 05 or P <0 01).Furthermore,“mai luo ning” could markedly decrease oxygen consumption of myocardium,lessen myocardial infarction size,reduce release of serum myocardium enzyme,and improve left ventricular ejection function compared with controls (all P <0 05).Conclusions:High dosage of “mai luo ning” may be of significant advantage in prevention of reperfusion injury associated with AMI,and it is suitable to use continuously for 1 week.

关 键 词:脉络宁 心肌梗塞 溶栓治疗 再灌注损伤 

分 类 号:R542.220.5[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象